{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:12:36Z","timestamp":1788966756293,"version":"build-2803163510"},"reference-count":16,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1002\/nau.23196","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T16:58:37Z","timestamp":1484326717000},"page":"1855-1859","source":"Crossref","is-referenced-by-count":34,"title":["Long-term compliance and results of intravesical botulinum toxin A injections in male patients"],"prefix":"10.1002","volume":"36","author":[{"given":"Mohammad S.","family":"Rahnama'i","sequence":"first","affiliation":[{"name":"Department of Urology; Zuyderland Medical Centre; Heerlen The Netherlands"},{"name":"Maastricht University; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom A.T.","family":"Marcelissen","sequence":"additional","affiliation":[{"name":"Department of Urology; Zuyderland Medical Centre; Heerlen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Brierley","sequence":"additional","affiliation":[{"name":"Maastricht University; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schurch","sequence":"additional","affiliation":[{"name":"Service de Neuro-R\u00e9habilitation, CHUV; Lausanne Suisse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Urology; Zuyderland Medical Centre; Heerlen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"10.1002\/nau.23196-BIB0001|nau23196-cit-0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0002|nau23196-cit-0002","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1002\/nau.23196-BIB0003|nau23196-cit-0003","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/nau.22295","article-title":"The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial\/ethnic group and age: results from OAB-POLL","volume":"32","author":"Coyne","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0004|nau23196-cit-0004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/nau.22642","article-title":"Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome","volume":"34","author":"Osborn","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0005|nau23196-cit-0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOU.0000000000000003","article-title":"New strategies in treating male lower urinary tract symptoms","volume":"24","author":"Fullhase","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1002\/nau.23196-BIB0006|nau23196-cit-0006","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23016","article-title":"Outcomes of different protocols of pelvic floor physical therapy and anti-cholinergics in women with wet over-active bladder: a 4-year follow-up","author":"Azuri","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0007|nau23196-cit-0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/nau.22797","article-title":"Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS","volume":"35","author":"Apostolidis","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0008|nau23196-cit-0008","article-title":"Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms","author":"Marcelissen","year":"2016","journal-title":"World J Urol"},{"key":"10.1002\/nau.23196-BIB0009|nau23196-cit-0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/iju.12205","article-title":"Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity","volume":"21","author":"Veeratterapillay","year":"2014","journal-title":"Int J Urol"},{"key":"10.1002\/nau.23196-BIB0010|nau23196-cit-0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2012.11282.x","article-title":"Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)","volume":"111","author":"Mohee","year":"2013","journal-title":"BJU Int"},{"key":"10.1002\/nau.23196-BIB0011|nau23196-cit-0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.eururo.2011.12.056","article-title":"Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study)","volume":"62","author":"Tincello","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.23196-BIB0012|nau23196-cit-0012","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrurol.2010.187","article-title":"Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity","volume":"7","author":"Dowson","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1002\/nau.23196-BIB0013|nau23196-cit-0013","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","article-title":"Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates","volume":"61","author":"Dowson","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.23196-BIB0014|nau23196-cit-0014","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23052","article-title":"Less Is More-A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivity","author":"Avallone","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.23196-BIB0015|nau23196-cit-0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00192-015-2839-x","article-title":"Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery","volume":"27","author":"Miotla","year":"2016","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.23196-BIB0016|nau23196-cit-0016","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/nau.22598","article-title":"The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: a systematic review and meta-analysis","volume":"34","author":"Cui","year":"2015","journal-title":"Neurourol Urodyn"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.23196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/nau.23196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:18:42Z","timestamp":1533601122000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/nau.23196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.23196","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,13]]}}}